- The global companion animal vaccines market is projected to reach $7.41 billion by 2030.
- The report forecasts a 10.3% compound annual growth rate through 2030.
- Rising pet healthcare spending and preventive care are expected to drive demand.
- North America remains the largest market, while Asia-Pacific is projected to see the fastest growth.
A new market report from The Business Research Company projects continued expansion of the global companion animal vaccines market, forecasting it will grow from $5.01 billion in 2026 to $7.41 billion by 2030 at a compound annual growth rate (CAGR) of 10.3%.
According to the report, market growth is being fueled by increasing pet ownership, greater awareness of preventive veterinary care, expanding veterinary services and rising spending on pet health. The report also cites continued investment in vaccine technologies, including recombinant and mRNA platforms, as supporting future growth.
The analysis notes that pet owners are increasingly viewing preventive care, including routine vaccination, as an essential part of maintaining long-term health for companion animals. Growth in pet insurance coverage and continued attention to zoonotic disease prevention are also expected to support vaccine demand.
North America is expected to remain the largest companion animal vaccines market, while Asia-Pacific is forecast to experience the fastest growth during the outlook period.
Information sourced from the company’s market report.
